Literature DB >> 10363583

Differences in substrate specificity among glutathione conjugates (GS-X) pump family members: comparison between multidrug resistance-associated protein and a novel transporter expressed on a cisplatin-resistant cell line (KCP-4).

K Ueda1, H Suzuki, S Akiyama, Y Sugiyama.   

Abstract

The substrate specificity of primary active transporters expressed on two kinds of human epidermoid KB-3-1 derived cell lines, C-A500 and KCP-4, was examined; the former expresses multidrug resistance-associated protein (MRP1), whereas the latter is resistant to cis-diamminedichloroplatinum (II) (cisplatin). Northern blot analysis indicated that neither P-glycoprotein, MRP1, MRP2 (canalicular multispecific organic anion transporter; cMOAT) nor MRP3 was overexpressed on KCP-4. Membrane vesicles isolated from C-A500 and KCP-4, but not from KB-3-1, exhibited the ATP-dependent uptake of glutathione conjugates (GS-X) such as leukotriene C4 and 2,4-dinitrophenyl-S-glutathione (DNP-SG), indicating the presence of GS-X pumps on these cells. The uptake of these GS-X by membrane vesicles from C-A500 was approximately twice that in the case of KCP-4. Kinetic analysis indicated that the Km and Vmax values for DNP-SG uptake were 2.56 and 1.43 microM, and 570 and 160 pmol/min/mg protein for C-A500 and KCP-4, respectively. In marked contrast, significant ATP-dependent uptake of glutathione-platinum complex was observed only in membrane vesicles from KCP-4, but not those from KB-3-1 and C-A500. The transport properties of estradiol-17beta-D-glucuronide (E(2)17betaG) were also different between the two cell lines. This was reflected in the findings that the ATP-dependent uptake of this conjugated metabolite in membrane vesicles from C-A500 (Km=2.33 microM, Vmax=34 pmol/min/mg protein) was much more extensive than that in the case of KCP-4 (Km=5.5 microM, Vmax=35 pmol/min/mg protein), and that comparable uptake was observed between KCP-4 and KB-3-1. Overall, a clear difference in substrate specificity among GS-X pump family members expressed on resistant tumor cells was demonstrated.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10363583      PMCID: PMC5926082          DOI: 10.1111/j.1349-7006.1999.tb00767.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  48 in total

Review 1.  Preclinical and clinical experience with cisplatin resistance.

Authors:  J L Marshall; P A Andrews
Journal:  Hematol Oncol Clin North Am       Date:  1995-04       Impact factor: 3.722

2.  A canalicular multispecific organic anion transporter (cMOAT) antisense cDNA enhances drug sensitivity in human hepatic cancer cells.

Authors:  K Koike; T Kawabe; T Tanaka; S Toh; T Uchiumi; M Wada; S Akiyama; M Ono; M Kuwano
Journal:  Cancer Res       Date:  1997-12-15       Impact factor: 12.701

3.  Functional expression of the rat liver canalicular isoform of the multidrug resistance-associated protein.

Authors:  J Madon; U Eckhardt; T Gerloff; B Stieger; P J Meier
Journal:  FEBS Lett       Date:  1997-04-07       Impact factor: 4.124

4.  Multiplicity of biliary excretion mechanisms for irinotecan, CPT-11, and its metabolites in rats.

Authors:  X Y Chu; Y Kato; Y Sugiyama
Journal:  Cancer Res       Date:  1997-05-15       Impact factor: 12.701

5.  Pharmacokinetics of CPT-11 in rhesus monkeys.

Authors:  M Inaba; Y Ohnishi; H Ishii; Y Tanioka; Y Yoshida; K Sudoh; H Hakusui; N Mizuno; K Ito; Y Sugiyama
Journal:  Cancer Chemother Pharmacol       Date:  1998       Impact factor: 3.333

6.  Functional analysis of a canalicular multispecific organic anion transporter cloned from rat liver.

Authors:  K Ito; H Suzuki; T Hirohashi; K Kume; T Shimizu; Y Sugiyama
Journal:  J Biol Chem       Date:  1998-01-16       Impact factor: 5.157

7.  Characterization of the ATP-dependent LTC4 transporter in cisplatin-resistant human KB cells.

Authors:  Y Chuman; Z S Chen; T Sumizawa; T Furukawa; M Haraguchi; Y Takebayashi; K Niwa; K Yamada; T Aikou; S Akiyama
Journal:  Biochem Biophys Res Commun       Date:  1996-09-04       Impact factor: 3.575

8.  Mechanism of glutathione S-conjugate transport in canalicular and basolateral rat liver plasma membranes.

Authors:  K Kobayashi; Y Sogame; H Hara; K Hayashi
Journal:  J Biol Chem       Date:  1990-05-15       Impact factor: 5.157

9.  Isolation of MOAT-B, a widely expressed multidrug resistance-associated protein/canalicular multispecific organic anion transporter-related transporter.

Authors:  K Lee; M G Belinsky; D W Bell; J R Testa; G D Kruh
Journal:  Cancer Res       Date:  1998-07-01       Impact factor: 12.701

10.  Active efflux system for cisplatin in cisplatin-resistant human KB cells.

Authors:  R Fujii; M Mutoh; K Niwa; K Yamada; T Aikou; M Nakagawa; M Kuwano; S Akiyama
Journal:  Jpn J Cancer Res       Date:  1994-04
View more
  1 in total

1.  Cisplatin nephrotoxicity: molecular mechanisms.

Authors:  Marie H Hanigan; Prasad Devarajan
Journal:  Cancer Ther       Date:  2003
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.